Global Artificial Intelligence Drug R&D market cagr 15.3%

Page 1


Artificial Intelligence Drug R&D

Market

Artificial Intelligence Drug R&D Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031

Request Sample Report

Artificial Intelligence Drug R&D Market Size and Growth

The Artificial Intelligence Drug R&D market is experiencing robust growth, driven by advancements in AI technologies and increased pharmaceutical investments. The market is projected to reach approximately $3.5 billion by 2025, reflecting a CAGR of over 30%. Current conditions favor innovation, streamlining drug discovery processes, and enhancing efficiency in research.

Request Sample Report

Companies Covered

(Covid 19 Impact Covered)

◍ IBM Watson

◍ BioXel

◍ Insilico Medicine

◍ Gatehouse Bio

◍ Google DeepMind

◍ Genpact Cora

◍ Cyclica Inc

◍ QuantumBlack

◍ Nq Medical

◍ Phenomic AI

◍ Palantir Technologies

The AI drug R&D market features key players like IBM Watson, Insilico Medicine, and DeepMind, leveraging AI for drug discovery, predictive modeling, and patient data analysis. These innovations enhance efficiency and reduce costs. Sales figures include IBM approximately $57 billion (2022) and Genpact around $4 billion (2022).

Request Sample Report

Market Segmentation

By Application

Drug Discovery

Precision Medicine

Request Sample Report

By Product

AI Platfrom

Analytics Service

Market Growth

Request Sample Report

$ X Billion USD

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.